BOSTON — In a new Endocrine Society scientific statement, experts recommend against the use of custom compounded bioidentical hormones to treat menopausal symptoms, thyroid disorders, and other hormone conditions.
In this video, Nanette Santoro, MD, chair of the task force that developed the statement, discusses how in many cases, “widespread use of custom compounded hormones lacks a logical basis” and may in fact be harmful.
The statement was made available at ENDO 2016.
Please login or register first to view this content.
Enjoying our content?
Thanks for visiting Endocrinology Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Endocrinology Advisor. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Please login or register first to view this content.